Krose 10 Tablet contains Rosuvastatin 10mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated levels of low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides, while modestly increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby decreasing cholesterol production in the liver and promoting increased clearance of LDL particles from the bloodstream. Krose 10 Tablet is prescribed to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and the need for revascularization procedures in patients with established coronary artery disease or those at high risk due to multiple risk factors. It is also utilized in the management of familial hypercholesterolemia. The medication is administered orally, typically once daily, with or without food, and dosage adjustments should be individualized based on therapeutic response and patient tolerance. Regular monitoring of lipid profiles, liver function tests, and creatine kinase levels is recommended during therapy to ensure efficacy and detect potential adverse effects such as myopathy or hepatotoxicity. Krose 10 Tablet should be used as part of a comprehensive treatment plan including diet, exercise, and lifestyle modifications.